其他有关资料在报告期是否变更情况 □适用 ?不适用 许昌开普检测研究院股份有限公司 2025 年半年度报告全文 四、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 ?否 本报告期 上年同期 本报告期比上年同期增减 营业收入（元） 111,331,192.32 107,850,944.77 3.23% 归属于上市公司股东的净利 润（元） 归属于上市公司股东的扣除 非经常性损益的净利润 38,867,279.32 34,025,464.33 14.23% （元） 经营活动产生的现金流量净 额（元） 基本每股收益（元/股） 0.39 0.38 2.63% 稀释每股收益（元/股） 0.39 0.38 2.63% 加权平均净资产收益率 3.77% 3.63% 0.14% 本报告期末 上年度末 本报告期末比上年度末增减 总资产（元） 1,111,128,904.91 1,156,643,926.36 -3.94% 归属于上市公司股东的净资 产（元） 五、境内外会计准则下会计数据差异 □适用 ?不适用 公司报告期不存在按照国际会计准则与按照中国会计准则披露的财务报告中净利润和净资产差异情况。 □适用 ...

许昌开普检测研究院股份有限公司 2025 年半年度财务报告 许昌开普检测研究院股份有限公司 Xuchang KETOP Testing Research Institute Co.,Ltd （未经审计） 许昌开普检测研究院股份有限公司 2025 年半年度财务报告 一、审计报告 半年度报告是否经过审计 □是 ?否 公司半年度财务报告未经审计。 二、财务报表 财务附注中报表的单位为：元 编制单位：许昌开普检测研究院股份有限公司 | 项目 | | | 单位：元 | | --- | --- | --- | --- | | | 期末余额 | | 期初余额 | | 流动资产： | | | | | 货币资金 | | 89,592,773.34 | 93,645,494.92 | | 结算备付金 | | | | | 拆出资金 | | | | | 交易性金融资产 | | 581,058,027.25 | 600,656,109.58 | | 衍生金融资产 | | | | | 应收票据 | | 1,037,213.00 | 4,519,121.10 | | 应收账款 | | 23,381,773.83 | 22,916,715. ...

Company Overview - The company is a third-party inspection and testing service provider for military equipment and civil aircraft products, offering a "one-stop" service capability that includes component screening, assembly, environmental and reliability testing, and electromagnetic compatibility testing [2][3]. Domestic Layout - The company has established two laboratories in Xi'an and additional labs in Chengdu, Beijing, and Wuhan, achieving preliminary coverage in the Northwest, Southwest, North China, and Central China regions [4]. Growth Drivers - The company has significantly enhanced its capabilities in environmental and reliability testing, particularly for aerospace and military products, and is increasing its investment in electromagnetic compatibility testing [5]. - The company is focusing on expanding its capabilities in component testing, including DPA, chip testing, and domestic verification, to improve its technical level [5]. Financial Performance - In 2024, the company faced losses due to a time lag in capacity release and ongoing investments in testing capabilities, which have not yet resulted in scale effects [6][7]. - The establishment of new subsidiaries in Beijing and Wuhan is still in the ramp-up phase, and the synergistic effects have not yet fully materialized [7]. Market Expectations - The company is actively positioning itself in the commercial aircraft and low-altitude economy sectors, which are expected to benefit from government initiatives and rapid market growth in aerospace [8]. - The commercial aerospace sector is anticipated to be one of the fastest-growing segments globally, driven by national encouragement for satellite and low-altitude industries [8]. Future Outlook - The company expects that as its revenue scale increases, capacity utilization will improve, leading to enhanced income and profitability [8]. - The electrical assembly business is a crucial part of the company's "one-stop" service chain, aimed at addressing core customer pain points related to quality, efficiency, and pricing [8].

Group 1: Financial Performance - In 2024, revenue decreased by 23.38%, while testing service revenue increased to 65.7% of total revenue [3][13] - Management expense ratio rose by 4.7 percentage points to 21.5% year-on-year [2] - Sales expense ratio increased by 3.2 percentage points to 18.7%, despite a revenue decline [3] Group 2: Profitability Metrics - Gross margin for testing business fell by 8.3 percentage points to 49.2% [2] - Gross margin for testing equipment sales plummeted to 19.3%, down 28.7 percentage points [5] - Environmental and reliability testing revenue dropped by 37.6%, yet gross margin rose to 58.1% [5] Group 3: Inventory and Cash Flow - Inventory turnover ratio decreased to 1.82 times, with inventory goods accounting for 42.7% [3] - Cash flow from operating activities improved but remained negative, with net cash outflow from investment activities expanding to 120 million [6] - Accounts receivable turnover days extended to 178 days, an increase of 42 days [6] Group 4: R&D and Innovation - R&D expenses grew by 15.6%, but the number of R&D personnel decreased by 12.4% [5] - R&D capitalized rate was 0, indicating all R&D expenses were expensed [7] - New customer revenue accounted for 28.3%, but the top five customers still represented 61.3% of total revenue [6] Group 5: Market Position and Strategy - The company is focusing on enhancing its service capabilities in the aerospace and defense sectors [10][14] - The proportion of inventory in progress rose to 34.6%, indicating potential production planning issues [4] - The company is actively engaging with investors to improve its market image and investor confidence [6][10]